申请人:TAKEDA PHARMACEUTICAL
公开号:WO2010147226A1
公开(公告)日:2010-12-23
Provided is a compound having a serotonin 5-HT2c receptor activating action, useful for lower urinary tract conditions, obesity and cancer. A compound represented by the formula (I0): wherein each symbol is as defined in the specification, or a salt thereof.